SCHEMBL9924070

SCHEMBL9924070

COC(=O)NC1CCC(N/C(=N\C(=O)c2ccccc2)Nc2cc(F)cc(Cl)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.40
APOB P04114 1/20 0.38
MTTP P55157 1/20 0.38
CHRM3 P20309 3/20 0.37
UBE2M P61081 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.36
CYP2D6 P10635 1/20 0.36
EPHX2 P34913 2/20 0.36
PRCP P42785 1/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
CRHR1 P34998 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
SLC6A9 P48067 1/20 0.34
SLC6A5 Q9Y345 1/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924090 0.93 APOB (0.40) GRM4APOBMTTPEPHX2PRCP
SCHEMBL9924069 0.91 GRM4 (0.38) GRM4APOBMTTPPRCPMEN1
SCHEMBL9924077 0.91 GRM4 (0.38) GRM4CHRM3UBE2MDCUN1D1CYP2D6
SCHEMBL9924332 0.90 SLC6A9 (0.41) GRM4EPHX2MEN1KMT2ASLC6A9
SCHEMBL9924257 0.90 GRM5 (0.42) APOBMTTPEPHX2MEN1ALDH1A1
SCHEMBL17206710 0.89 MEN1 (0.38) GRM4APOBMTTPEPHX2PRCP
SCHEMBL9924333 0.89 NPC1 (0.44) GRM4MEN1KMT2ACRHR1PDE4A
SCHEMBL9924330 0.87 GRM5 (0.47) MEN1ALDH1A1KMT2A
SCHEMBL9924083 0.86 NPC1 (0.44) GRM4MEN1KMT2ACRHR1
SCHEMBL9924071 0.86 KMT2A (0.43) MEN1ALDH1A1KMT2ACRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed